Targeted next-generation sequencing identifies the disruption of the SHANK3 and RYR2 genes in a patient carrying a de novo t(1;22)(q43;q13.3) associated with signs of Phelan-McDermid syndrome - Bonaglia, M C; Bertuzzo, S; Ciaschini, A M (Mol Cytogenet, 2020)